HPV DNA testing is shown to be significantly more effective compared to pap smear/cytology for cervical cancer screening. In this webinar, you will learn how to implement HPV DNA testing as a primary screening tool for cervical cancer.

• How to address multidisciplinary challenges during the transition phase from pap smear/cytology to HPV DNA testing?
• What are the considerations when choosing a reliable and clinically relevant HPV DNA test?
• What are some practical tips in supporting implementation of HPV DNA testing as a primary screening tool in your country?